NMDA-receptors functional assays for CNS diseases

Whatever your therapeutic area (cognitive disorders, schizophrenia, depression, stroke, neuropathic pain, etc.) you are targeting NMDA receptors and you need to get clean, precise and robust pharmacological profiles of your compounds. For more than 13 years Esther STEIDL and her team have developed multiple assays based on the Multi-Electrode Array technique (MEA recordings) to document […]

Ketamine July 2017 multi electrode array psychiatric

Psychiatric diseases to be understood and treated ONLY by physiological measurements.

Recent epidemiological and genetic studies have pointed out common genes overexpression and/or alteration in psychiatric disorders and for some of these diseases, alteration in brain wiring functions as measured by high-scale brain scan. The first study (published by Dan Geschwind and colleagues from UCLA) reveals that many mental illnesses, such as autism, schizophrenia, bipolar disorders, […]

neurosyn

Neurosyn, new product from Neuroservice and Synapcell

NEUROSERVICE and SYNAPCELL are very pleased to announce the launch of a joint product, NEUROSYN. This new offer combines a unique in vitro and in vivo approach to document compound’s effects on brain oscillations. NEUROSERVICE has developed over the last 3 years in vitro Multi-Electrode Array measurements to record and to document 2D-oscillations in hippocampal […]